Stock Market

Lupin’s Mandideep unit receives US FDA observations

Like this story, share it with millions of investors on M3

Lupins Mandideep unit receives US FDA observations

Lupin’s Mandideep unit has been flagged by the US FDA. In particular, the active pharmaceutical ingredient (API) and formulations units of the plant have received two observations each.